|
🐜
|
Theranostic iridium(III) complexes as one- and two-photon phosphorescent trackers to monitor autophagic lysosomes.
8 auth.
Liang He,
Cai-Ping Tan,
R. Ye,
Yi Zhao,
Yahong Liu,
Qiang Zhao,
...
L. Ji,
Z. Mao
|
7 |
2014 |
7
🐜
|
|
🦁
|
Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
R. Ye,
Cai-Ping Tan,
Liang He,
Mu-He Chen,
L. Ji,
Z. Mao
|
6 |
2014 |
6
🦁
|
|
🦁
|
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.
R. Ye,
Cai-Ping Tan,
Mu-He Chen,
Liang Hao,
L. Ji,
Z. Mao
|
6 |
2016 |
6
🦁
|
|
🦁
|
Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents.
R. Ye,
Zhuofeng Ke,
Cai-Ping Tan,
Liang He,
L. Ji,
Z. Mao
|
6 |
2013 |
6
🦁
|
|
🦁
|
Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
R. Ye,
Cai-Ping Tan,
L. Ji,
Z. Mao
|
5 |
2016 |
5
🦁
|
|
🐜
|
Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies.
8 auth.
Liang He,
Sindy Liao,
Cai-Ping Tan,
R. Ye,
Yu-Wen Xu,
Meng-Meng Zhao,
...
L. Ji,
Z. Mao
|
5 |
2013 |
5
🐜
|
|
🐜
|
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
7 auth.
Fang-Xin Wang,
Mu-He Chen,
Xiao-Ying Hu,
R. Ye,
Cai-Ping Tan,
L. Ji,
...
Z. Mao
|
5 |
2016 |
5
🐜
|
|
🦁
|
Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
R. Ye,
Jian-Jun Cao,
Cai-Ping Tan,
L. Ji,
Z. Mao
|
5 |
2017 |
5
🦁
|
|
🦁
|
A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction.
R. Ye,
Cai-Ping Tan,
Yan-Nan Lin,
L. Ji,
Z. Mao
|
5 |
2015 |
5
🦁
|
